Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease ML Evatt, MR DeLong, N Khazai, A Rosen, S Triche, V Tangpricha Archives of neurology 65 (10), 1348-1352, 2008 | 538 | 2008 |
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 316 | 2014 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease JL Vitek, RAE Bakay, A Freeman, M Evatt, J Green, W McDonald, ... Annals of Neurology: Official Journal of the American Neurological …, 2003 | 299 | 2003 |
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation—critique and recommendations by movement disorders task force on rating scales for … ML Evatt, KR Chaudhuri, KL Chou, E Cubo, V Hinson, K Kompoliti, ... Movement disorders: official journal of the Movement Disorder Society 24 (5 …, 2009 | 208 | 2009 |
Sialorrhea in Parkinson's disease: a review KL Chou, M Evatt, V Hinson, K Kompoliti Movement Disorders 22 (16), 2306-2313, 2007 | 188 | 2007 |
High prevalence of hypovitaminosis D status in patients with early Parkinson disease ML Evatt, MR DeLong, M Kumari, P Auinger, MP McDermott, ... Archives of neurology 68 (3), 314-319, 2011 | 180 | 2011 |
Complications of gamma knife surgery for Parkinson disease MS Okun, NP Stover, T Subramanian, M Gearing, BH Wainer, CA Holder, ... Archives of Neurology 58 (12), 1995-2002, 2001 | 166 | 2001 |
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease JL Juncos, VJ Roberts, ML Evatt, RD Jewart, CD Wood, LS Potter, HC Jou, ... Movement Disorders 19 (1), 29-35, 2004 | 148 | 2004 |
An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson’s disease CM Epstein, ML Evatt, A Funk, L Girard-Siqueira, N Lupei, L Slaughter, ... Clinical Neurophysiology 118 (10), 2189-2194, 2007 | 122 | 2007 |
Modification of human spinal stretch reflexes: preliminary studies ML Evatt, SL Wolf, RL Segal Neuroscience letters 105 (3), 350-355, 1989 | 117 | 1989 |
Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial B Bluett, DM Togasaki, D Mihaila, M Evatt, M Rezak, S Jain, ... Jama 326 (10), 926-939, 2021 | 102 | 2021 |
Vitamin D from different sources is inversely associated with Parkinson disease L Wang, ML Evatt, LG Maldonado, WR Perry, JC Ritchie, GW Beecham, ... Movement disorders 30 (4), 560-566, 2015 | 95 | 2015 |
Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease TA Zesiewicz, M Evatt, CP Vaughan, I Jahan, C Singer, R Ordorica, ... Parkinsonism & related disorders 21 (5), 514-520, 2015 | 82 | 2015 |
Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes HA Jinnah, E Goodmann, AR Rosen, M Evatt, A Freeman, S Factor Journal of neurology 263, 1188-1194, 2016 | 66 | 2016 |
Adult-onset dystonia ML Evatt, A Freeman, S Factor Handbook of clinical neurology 100, 481-511, 2011 | 66 | 2011 |
Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor NP Stover, MS Okun, ML Evatt, DV Raju, RAE Bakay, JL Vitek Archives of neurology 62 (1), 141-143, 2005 | 65 | 2005 |
Injectable DaxibotulinumtoxinA in cervical dystonia: a phase 2 dose‐escalation multicenter study J Jankovic, D Truong, AT Patel, A Brashear, M Evatt, RG Rubio, CK Oh, ... Movement Disorders Clinical Practice 5 (3), 273-282, 2018 | 59 | 2018 |
Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findings J Green, WM McDonald, JL Vitek, M Haber, H Barnhart, RAE Bakay, ... Neurology 58 (6), 858-865, 2002 | 59 | 2002 |
Association between vitamin B12-containing supplement consumption and prevalence of biochemically defined B12 deficiency in adults in NHANES III (third national health and … ML Evatt, PD Terry, TR Ziegler, GP Oakley Jr Public health nutrition 13 (1), 25-31, 2010 | 56 | 2010 |
Potential influences of complementary therapy on motor and non-motor complications in Parkinson’s disease TA Zesiewicz, ML Evatt CNS drugs 23, 817-835, 2009 | 52 | 2009 |